Evidence map›Paper›PMID 36138060›Full record

ArticleScientific reports2022

Longitudinal behavioral changes and factors related to reinforced risk aversion behavior among patients with chronic kidney disease during the COVID-19 pandemic.

Min Woo Kang, Yaerim Kim, Inae Lee, Hyunwoong Park, Jae Yoon Park, Jung Nam An, Kyung Don Yoo, Yong Chul Kim, Na-Youn Park, Younglim Kho and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04679168 (Change of Environmental Chemical Exposures and Prevalence of Chronic Kidney Disease After Epidemiological Spread of SARS-CoV-2), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04679168 unknown statusnot on this map

Change of Environmental Chemical Exposures and Prevalence of Chronic Kidney Disease After Epidemiological Spread of SARS-CoV-2 (COVID-19)

Typeobservational_patient_registrySponsorSeoul National University HospitalRan2020 to 2021Enrolled310ConditionsCovid19, Environmental Exposure, Chronic Kidney Diseases
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Min Woo KangDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Yaerim KimDepartment of Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea.
Inae LeeSchool of Public Health, Seoul National University, Seoul, Republic of Korea.
Hyunwoong ParkDepartment of Laboratory Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Jae Yoon ParkDepartment of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.
Jung Nam AnDepartment of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
Kyung Don YooDepartment of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
Yong Chul KimDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Na-Youn ParkDepartment of Health, Environment and Safety, Eulji University, Seongnam, Republic of Korea.
Younglim KhoDepartment of Health, Environment and Safety, Eulji University, Seongnam, Republic of Korea.
Kyungho ChoiSchool of Public Health, Seoul National University, Seoul, Republic of Korea.
Jung Pyo LeeDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Jeonghwan LeeDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. woogaelee@naver.com.
Seoul National University · KREulji University · KRSeoul National University Hospital · KRSNUH SMG-SNU Boramae Medical Center · KRDongguk University Ilsan Hospital · KRHallym University Sacred Heart Hospital · KRKeimyung University · KRUlsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In patients with chronic kidney disease (CKD), coronavirus disease 2019 (COVID-19) has a higher mortality rate than the general population; therefore, prevention is vital. To prevent COVID-19 infection, it is important to study individuals' risk aversion behavior. The objective of this study was to understand how the behavioral characteristics of physical distancing, hygiene practice, and exercise changed in patients with CKD during the COVID-19 pandemic and to identify the characteristics of patients who showed weakened or strengthened behavioral changes. We analyzed data from the Study on Kidney Disease and Environmental Chemicals (Clinical Trial No. NCT04679168), that examined a prospective cohort of patients with CKD. This cohort included patients with CKD who visited the participating hospitals for the first time between June and October 2020 and the second time between October 2020 and January 2021. Data on demographics, socio-economic details, and behavioral characteristics were collected through a questionnaire survey. Using a multivariable logistic regression model, we identified whether COVID-19 infection risk perception and previous strong behavioral changes affected behavioral changes during the first and second visits. A total of 277 patients (33.2% females) were included in the analysis. Nine out of 12 behaviors were reinforced at the first visit, and five out of nine reinforced behaviors were weakened at the second visit. A high-risk perception of COVID-19 infection was not associated with the tendency of overall behavioral reinforcement or maintaining behaviors in an enhanced state at the second visit. Strong behavioral changes at the patients' first visit to the hospital were associated with a tendency to strengthen or maintain reinforced behaviors at the second visit (adjusted odds ratio 1.99, 95% confidence interval 1.19-3.34; P = 0.009). Even if the initial COVID-19 risk perception is high, behavioral changes worsen over time. Individuals who showed more active behavioral changes at the beginning of the COVID-19 pandemic tended to maintain reinforced behavior over time. Continuous education and monitoring are needed to maintain changed behaviors, especially in patients with a high initial COVID-19 risk perception.

Indexed as

COVID-19Renal Insufficiency, ChronicFemaleHumansMalePandemicsProspective StudiesSARS-CoV-2

Identifiers

PMID36138060
PMCPMC9493162
OpenAlexW4296617598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.